Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
October 2013 Life Science Industry Research Reports
Atacicept (Systemic Lupus Erythematosus and Lupus Nephritis) – Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
Tabalumab (Systemic Lupus Erythematosus and Lupus Nephritis) – Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
Blisibimod (Systemic Lupus Erythematosus and Lupus Nephritis) – Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis) – Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
Benlysta (Systemic Lupus Erythematosus and Lupus Nephritis) – Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis – Japan Drug Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis – UK Drug Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis – Spain Drug Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis – Italy Drug Forecast and Market Analysis to 2022
Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations […]
Stay In Touch